Ken O'Flynn

2058. Deputy Ken O'Flynn asked the Minister for Health whether the absence of any national clinical audit relating to procedures funded under the Treatment Abroad Scheme since 2020 is considered acceptable from a patient-safety and governance perspective; and if she will make a statement on the matter. [42505/26]

2059. Deputy Ken O'Flynn asked the Minister for Health whether her Department or the HSE has conducted any risk assessment regarding the absence of national clinical outcome auditing for procedures funded under the treatment abroad scheme; and if she will make a statement on the matter. [42506/26]

2060. Deputy Ken O'Flynn asked the Minister for Health whether the HSE maintains any mechanism to systematically monitor complication rates, revision procedures, adverse outcomes, readmissions, or long-term follow-up care requirements arising from procedures funded under the Treatment Abroad Scheme; and if she will make a statement on the matter. [42507/26]

2061. Deputy Ken O'Flynn asked the Minister for Health whether any national framework exists governing post-treatment outcome monitoring for patients returning to Ireland following procedures funded under the Treatment Abroad Scheme; and if she will make a statement on the matter. [42508/26]

2062. Deputy Ken O'Flynn asked the Minister for Health whether the HSE National Centre for Clinical Audit has ever been requested by her Department, the HSE, or the Treatment Abroad Scheme to consider conducting a national clinical audit relating to procedures funded under the Treatment Abroad Scheme; and if she will make a statement on the matter. [42509/26]

2063. Deputy Ken O'Flynn asked the Minister for Health whether any official within her Department or the HSE holds responsibility for assessing whether procedures funded under the Treatment Abroad Scheme should be subject to national clinical audit or outcome monitoring; and if she will make a statement on the matter. [42510/26]

2064. Deputy Ken O'Flynn asked the Minister for Health whether the HSE maintains any standardised national framework for measuring the effectiveness or value for money of agency-supported clinics, additional theatre sessions, diagnostics initiatives or insourcing arrangements; and if she will make a statement on the matter. [42512/26]

2065. Deputy Ken O'Flynn asked the Minister for Health whether regional performance and planning divisions use uniform metrics when monitoring waiting-list reduction initiatives; if so, to provide those metrics; and if she will make a statement on the matter. [42513/26]

2066. Deputy Ken O'Flynn asked the Minister for Health whether any comparative analysis has been undertaken between hospitals or regions regarding the cost-effectiveness of additional sessions or agency-supported waiting-list initiatives since 2020; and if she will make a statement on the matter. [42514/26]

2067. Deputy Ken O'Flynn asked the Minister for Health whether the HSE can identify the total number of waiting-list removals attributable specifically to insourcing, agency-supported clinics, weekend sessions or additional diagnostics capacity in each year from 2020 to 2026; and if she will make a statement on the matter. [42515/26]

2068. Deputy Ken O'Flynn asked the Minister for Health whether the Comptroller and Auditor General, Internal Audit, or any external body has assessed the governance, monitoring, or value-for-money arrangements relating to waiting-list reduction initiatives supported by agencies or third-party providers; and if she will make a statement on the matter. [42516/26]

2175. Deputy Ken O'Flynn asked the Minister for Health the total expenditure on agency staffing in each of the years 2023, 2024, 2025 and to date in 2026. [43156/26]

2176. Deputy Ken O'Flynn asked the Minister for Health whether the HSE records the actual hourly rates paid to agency providers by grade and specialty; and if so, if she will provide a breakdown. [43157/26]

2177. Deputy Ken O'Flynn asked the Minister for Health the reason the HSE does not maintain a central cost comparator database for agency staffing expenditure. [43158/26]

2178. Deputy Ken O'Flynn asked the Minister for Health whether her Department has assessed the value-for-money implications of the HSE not maintaining a central database comparing agency staffing costs with directly employed staff costs. [43159/26]

2179. Deputy Ken O'Flynn asked the Minister for Health the amount paid annually in agency fees, commissions and VAT associated with agency staffing in each of the years 2023, 2024, 2025 and to date in 2026. [43160/26]

2180. Deputy Ken O'Flynn asked the Minister for Health whether the HSE has any plans to establish a national agency workforce cost monitoring framework; and if so, the timeline for implementation. [43161/26]

2181. Deputy Ken O'Flynn asked the Minister for Health the top 20 agency suppliers by expenditure in each of the years 2023, 2024 and 2025. [43162/26]

2184. Deputy Ken O'Flynn asked the Minister for Health whether a national written risk assessment has ever been completed in relation to winter patient transfer arrangements across the acute hospital system; and if so, to provide the date of completion and a copy of the assessment. [43223/26]

2185. Deputy Ken O'Flynn asked the Minister for Health who holds responsibility for approving patient transfer escalation frameworks used during winter pressures. [43224/26]

2186. Deputy Ken O'Flynn asked the Minister for Health whether any adverse incident review has identified patient transfer during winter pressures as a contributory factor in patient harm since 2020. [43225/26]

2187. Deputy Ken O'Flynn asked the Minister for Health whether the HSE maintains a national register of incidents, complaints, serious reportable events or adverse outcomes linked to inter-hospital transfers. [43226/26]

2188. Deputy Ken O'Flynn asked the Minister for Health whether HIQA has ever reviewed the governance of winter patient transfer arrangements. [43227/26]

2189. Deputy Ken O'Flynn asked the Minister for Health whether any audit has been conducted comparing outcomes for patients transferred during periods of peak escalation against those who remained in their originating hospital. [43228/26]

2190. Deputy Ken O'Flynn asked the Minister for Health whether the HSE independently verifies that foreign healthcare providers treating minors under the Treatment Abroad Scheme comply with local child protection legislation, and if so, the process used to conduct such verification. [43240/26]